Cell Therapy and Protein Good Manufacturing Practice Facility

Mission: To accelerate the translation of scientific discoveries into human clinical trials as safely, efficiently, and cost effectively as possible according to  high quality standards.


At the GBF we collaborate with basic science and clinical investigators to successfully translate laboratory discoveries into early phase clinical trials.

The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus is a 14,000 square ft. GMP compliant manufacturing facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established in 2015 though partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children’s Hospital Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.


Values:

  • Safety
  • Quality
  • Innovation
  • Integrity
  • Efficiency
  • Collaboration

Expertise:

  • Cell-Based Therapies
  • Protein Biologics
  • Quality Assurance
  • Quality Control
  • Regulatory support

Clients:

  • Academic Researchers
  • Clinicians
  • Early Stage Biotechnology Companies
  • Established Pharmaceutical Companies


Location: Conveniently located on the University of Colorado Anschutz Medical Campus, which is adjacent to Children’s Hospital Colorado and the University of Colorado Hospital.